Incyte



Ebitda Zmiana Data
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Exelixis USD 171.1M 24.2M 2025-01
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
MacroGenics USD 56.03M 112.4M 2024-09
Merck USD 7.12B 1.06B 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Pfizer USD 4.71B 3.04B 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Incyte - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.